For Immediate Release Contact marketingcommunications@us.medical.canon
March 16, 2010
ATLANTA, March 16, 2010 – Health care facilities use ultrasound as a first-line diagnostic exam to quickly and efficiently perform a range of patient exams, including cardiac imaging. Developed to meet these demanding clinical needs, Toshiba America Medical Systems, Inc. will showcase the advanced cardiac capabilities of its AplioTM MX and Aplio ArtidaTM ultrasound systems at this year’s American College of Cardiology (ACC) annual meeting in Atlanta, March 14 – 16, 2010 (Booth # 1944). This is the first appearance of the Aplio MX at ACC.
Introduced in November 2009, Toshiba’s new Aplio MX ultrasound system is a mid-sized, cart-based system that improves patient care by offering increased portability and patient access, with the ability to perform premium ultrasound exams using this smaller system. The functional Aplio MX allows physicians to quickly and efficiently perform a range of advanced ultrasound exams, including cardiac, on patients when space is limited, such as in the emergency department, intensive care unit, outside the lab and at the patient’s bedside.
Features of the Aplio MX include:
• Contrast Harmonics to provide the ability to use bubble based contrast agents that help to provide better tissue definition on difficult-to-image patients during echocardiograms.
• Differential Tissue Harmonic Imaging for the better imaging of difficult-to-image patients, like bariatric, without sacrificing resolution to give superior border and tissue definition.
• ApliPure+ to enhance both image clarity and detail definition with real-time compounding technology to simultaneously perform spatial and frequency compounding during transmitting and receiving.
• Advanced Dynamic Flow to provide color Doppler imaging at an unprecedented level and show flow with directional information for even the smallest vessels.
• Tissue Doppler Imaging Quantification (TDIQ) software to perform various analyses by Angle Corrected Displacement and Strain to measure myocardial viability.
Toshiba’s Aplio Artida ultrasound system offers the power of 4D imaging in an everyday clinical setting. Artida offers advanced quantitative analysis tools with the world’s first 3D Wall Motion Tracking. 3D Wall Motion Tracking allows sonographers and physicians to quickly and accurately identify wall motion defects and the timing of cardiac events. This greatly improves the detection of wall motion abnormalities in many cardiac disease states and Cardiac Resynchronization Therapy (CRT), and helps physicians optimize pacemaker settings.
Using Artida’s real-time, multi-planar reformatting capabilities, physicians can assess global and regional LV function, including volumetric LV ejection fraction. Arbitrary views of the heart, not available in 2D imaging, are also obtained to help with surgical planning. The 3D Wall Motion Tracking features from Toshiba allow the user to obtain angle-independent, global and regional information about myocardial contraction.
“Toshiba is dedicated to listening to our customers and developing comprehensive imaging systems offering value while meeting a range of customer needs,” explained Doug Ryan, vice president, Marketing and Strategic Development, Toshiba. “Toshiba’s Aplio MX and Aplio Artida deliver on this commitment by offering the flexibility to perform a variety of high-end cardiology exams in multiple clinical settings.”
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, MRI and information systems. Toshiba Corp. is a worldwide leader in technology, electronic and electrical products, digital consumer products, electronic devices and components, power systems, industrial and social infrastructure systems and home appliances. Toshiba was founded in 1875 and today operates a global network of more than 740 companies with 199,000 employees worldwide and annual sales surpassing $73 billion. For more information, visit Toshiba’s web site at www.medical.toshiba.com.